Nicorette Cherry Peppermint - Haleon US Holdings LLC

Manufacturer
Haleon US Holdings LLC
Effective date
2025-06-09
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:52:11

Label at a glance#

ProductNicorette Cherry Peppermint
Active ingredientNICOTINE
Label structure13 sections

Dosage and administration

if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you. before using this product, read the enclosed User’s Guide for complete directions and other important information begin using the lozenge on your quit day if you smoke your first cigarette within 30 minutes of waking up, use 4 mg nicotine lozenge if you smoke your first cigarette more tha...

Label contents#

Full prescribing information#

Active ingredient (in each lozenge)– 2 mg

OTC - ACTIVE INGREDIENT SECTION

Nicotine polacrilex, 2 mg

Active ingredient (in each lozenge)– 4 mg

OTC - ACTIVE INGREDIENT SECTION

Nicotine polacrilex, 4 mg

Purpose

OTC - PURPOSE SECTION

Stop smoking aid

Use

INDICATIONS & USAGE SECTION

  • reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Warnings

WARNINGS SECTION

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider.

OTC - PREGNANCY OR BREAST FEEDING SECTION

Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
  • high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
  • stomach ulcer or diabetes
  • history of seizures

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

  • using a non-nicotine stop smoking drug
  • taking a prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • mouth problems occur
  • persistent indigestion or severe sore throat occurs
  • irregular heartbeat or palpitations occur
  • you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat
  • you have symptoms of an allergic reaction (such as difficulty breathing or rash)

Keep out of reach of children and pets.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.
  • before using this product, read the enclosed User’s Guide for complete directions and other important information
  • begin using the lozenge on your quit day
  • if you smoke your first cigarette within 30 minutes of waking up,use 4 mg nicotine lozenge
  • if you smoke your first cigarette more than 30 minutes after waking up,use 2 mg nicotine lozenge according to the following 12 week schedule:

Weeks 1 to 6

Weeks 7 to 9

Weeks 10 to 12

1 lozenge every 1 to 2 hours

1 lozenge every 2 to 4 hours

1 lozenge every 4 to 8 hours

  • nicotine lozenge is a medicine and must be used a certain way to get the best results
  • place the lozenge in your mouth and allow the lozenge to slowly dissolve. Minimize swallowing. Do not chew or swallow lozenge.
  • you may feel a warm or tingling sensation
  • occasionally move the lozenge from one side of your mouth to the other until completely dissolved
  • do not eat or drink 15 minutes before using or while the lozenge is in your mouth
  • to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks
  • do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects
  • do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
  • it is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.

Other information

SPL UNCLASSIFIED SECTION

  • store between 20°-25°C (68°-77°F)
  • keep the vial tightly closed and protect from light

Inactive ingredients (2 mg)

INACTIVE INGREDIENT SECTION

acesulfame potassium, anhydrous dibasic calcium phosphate, carmine (color), crospovidone, flavors, hypromellose, magnesium stearate, mannitol, microcrystalline cellulose, sodium bicarbonate, sodium carbonate anhydrous, sucralose, xanthan gum, xylitol

Inactive ingredients (4 mg)

INACTIVE INGREDIENT SECTION

acesulfame potassium, anhydrous dibasic calcium phosphate, carmine (color), crospovidone, flavors, hypromellose, magnesium stearate, mannitol, microcrystalline cellulose, sodium bicarbonate, sodium carbonate anhydrous, sucralose, xanthan gum, xylitol

Questions or comments?

OTC - QUESTIONS SECTION

call toll-free 1-888-569-1743

Additional Information

SPL UNCLASSIFIED SECTION

TO INCREASE YOUR SUCCESS IN QUITTING:

  1. You must be motivated to quit.
  2. Use Enough– Use at least 9 Nicorettemini Lozenges per day during the first six weeks.
  3. Use Long Enough– Use Nicorettemini Lozenges for the full 12 weeks.
  4. Use with a support programas directed in the enclosed User’s Guide.

Opening Directions:

Squeeze child resistant tabs on each side. Flip up the top of vial. Turn upside down and shake to remove lozenge.

For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.comor see inside for more details.

Flip open for Directions and additional information

Retain this package for complete product information

  • not for sale to those under 18 years of age
  • proof of age required
  • not for sale in vending machines or from any source where proof of age cannot be verified

TAMPER EVIDENT FEATURE:Do not use if clear neckband printed “SEALED FOR SAFETY” is missing or broken. Retain outer carton for full product uses, directions and warnings.

Principal Display Panel – 2 mg

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NEW CHERRY PEPPERMINT FLAVOR

NDC 0135-8070-20

HALEON

$5.00Coupon Inside

NICORETTE

nicotine polacrilex lozenge, 2 mg

stop smoking aid

mini

Lozenge

2 mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE MORE THAN 30 MINUTES AFTER WAKING UP.

If you smoke your first cigarette WITHIN30 MINUTES of waking up, use Nicorette 4 mg Lozenge.

20 LOZENGES, 2 mg Each

CHERRY PEPPERMINT

Nicorette Mini Lozenge Cherry Peppermint 2 mg 20 ct.jpg
Nicorette Mini Lozenge Cherry Peppermint 2 mg 20 ct.jpg

Principal Display Panel – 4 mg

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NEW CHERRY PEPPERMINT FLAVOR

NDC 0135-8071-20

HALEON

$5.00Coupon Inside

NICORETTE

nicotine polacrilex lozenge, 4 mg

stop smoking aid

mini

Lozenge

4 mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE WITHIN 30 MINUTES OF WAKING UP.

If you smoke your first cigarette MORE THAN30 MINUTES after waking up, use Nicorette 2 mg Lozenge.

20 LOZENGES, 4 mg Each

CHERRY PEPPERMINT

Nicorette Mini Lozenge Cherry Peppermint 4 mg 20 ct.jpg
Nicorette Mini Lozenge Cherry Peppermint 4 mg 20 ct.jpg

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
968849Nicorette 2 MG Oral LozengePSN2
968851Nicorette 4 MG Oral LozengePSN2
359817nicotine 2 MG Oral LozengePSN2
359818nicotine 4 MG Oral LozengePSN2
968849nicotine 2 MG Oral Lozenge [Nicorette]SBD2
968851nicotine 4 MG Oral Lozenge [Nicorette]SBD2
359817nicotine 2 MG Oral LozengeSCD2
359818nicotine 4 MG Oral LozengeSCD2
968849Nicorette 2 MG (nicotine polacrilex 11.1 MG) Oral LozengeSY2
968849Nicorette 2 MG Oral LozengeSY2
968849Nicorette 2 MG TrocheSY2
968851Nicorette 4 MG (nicotine polacrilex 22.2 MG) Oral LozengeSY2
968851Nicorette 4 MG Oral LozengeSY2
359817nicotine 2 MG (as nicotine polacrilex 11.1 MG) Oral LozengeSY2
359817nicotine 2 MG TrocheSY2
359818nicotine 4 MG (as nicotine polacrilex 22.2 MG) Oral LozengeSY2
359818nicotine 4 MG TrocheSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
NICOTINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508
dbebfdf8-6e0c-cfa8-fdbc-e5d7f1bf1562Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0135-8070-20NicoretteCherry Peppermint20 in 1 VIALLOZENGE202
0135-8070-20NicoretteCherry Peppermint1 in 1 PACKAGELOZENGE12
0135-8070-81NicoretteCherry Peppermint27 in 1 VIALLOZENGE272
0135-8070-81NicoretteCherry Peppermint3 in 1 PACKAGELOZENGE32
0135-8071-20NicoretteCherry Peppermint1 in 1 PACKAGELOZENGE12
0135-8071-20NicoretteCherry Peppermint20 in 1 VIALLOZENGE202
0135-8071-81NicoretteCherry Peppermint27 in 1 VIALLOZENGE272
0135-8071-81NicoretteCherry Peppermint3 in 1 PACKAGELOZENGE32

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0135-80700135-8070-20, 0135-8070-81
0135-80710135-8071-20, 0135-8071-81

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 26 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N022360-001NICORETTENICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-18
N022360-002NICORETTENICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-18

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N022360-00189407722029-04-30Drug product2015-02-25
N022360-00185011642029-06-14Drug product2013-09-05
N022360-00289407722029-04-30Drug product2015-02-25
N022360-00285011642029-06-14Drug product2013-09-05

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-1884e616aacf4f…
2026-09-14 22:38:342026-08N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-1884e616aacf4f…
2026-08-18 06:07:402026-07N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-18caaa826d4ba7…
2026-08-18 06:07:402026-07N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-18caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-18011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-18011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-1831067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-1831067a03dcf5…
2025-08-23 18:47 UTC2025-08N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-186a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-186a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-18fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-18fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-18b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-18b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-1803ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-1803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-182680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-182680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-185bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-185bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-18d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-18d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-18d06236e962d9…
2024-10-29 15:01 UTC2024-10N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-18d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-1879d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-1879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-18301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-18301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-181e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-181e350fbaab3a…
2024-05-31 18:47 UTC2024-05N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-188072bd15b7f6…
2024-05-31 18:47 UTC2024-05N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-188072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-185c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-185c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-185d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-185d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-184b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-184b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N022360-001NICORETTEEQ 2MG BASETROCHE/LOZENGE / ORALRLD2009-05-1874a2ff9319b5…
2019-12-13 00:20 UTC2019-12N022360-002NICORETTEEQ 4MG BASETROCHE/LOZENGE / ORALRLD, RS2009-05-1874a2ff9319b5…

Observed Orange Book patent history#

Patent history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N022360-00189407722029-04-30Drug product2015-02-2584e616aacf4f…
2026-09-14 22:38:342026-08N022360-00185011642029-06-14Drug product2013-09-0584e616aacf4f…
2026-09-14 22:38:342026-08N022360-00289407722029-04-30Drug product2015-02-2584e616aacf4f…
2026-09-14 22:38:342026-08N022360-00285011642029-06-14Drug product2013-09-0584e616aacf4f…
2026-08-18 06:07:402026-07N022360-00189407722029-04-30Drug product2015-02-25caaa826d4ba7…
2026-08-18 06:07:402026-07N022360-00185011642029-06-14Drug product2013-09-05caaa826d4ba7…
2026-08-18 06:07:402026-07N022360-00289407722029-04-30Drug product2015-02-25caaa826d4ba7…
2026-08-18 06:07:402026-07N022360-00285011642029-06-14Drug product2013-09-05caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N022360-00189407722029-04-30Drug product2015-02-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022360-00185011642029-06-14Drug product2013-09-05011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022360-00289407722029-04-30Drug product2015-02-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02N022360-00285011642029-06-14Drug product2013-09-05011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022360-00189407722029-04-30Drug product2015-02-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022360-00185011642029-06-14Drug product2013-09-0531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022360-00289407722029-04-30Drug product2015-02-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022360-00285011642029-06-14Drug product2013-09-0531067a03dcf5…
2025-08-23 18:47 UTC2025-08N022360-00189407722029-04-30Drug product2015-02-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022360-00185011642029-06-14Drug product2013-09-056a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022360-00289407722029-04-30Drug product2015-02-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08N022360-00285011642029-06-14Drug product2013-09-056a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022360-00189407722029-04-30Drug product2015-02-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022360-00185011642029-06-14Drug product2013-09-05fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022360-00289407722029-04-30Drug product2015-02-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022360-00285011642029-06-14Drug product2013-09-05fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022360-00189407722029-04-30Drug product2015-02-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022360-00185011642029-06-14Drug product2013-09-05b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022360-00289407722029-04-30Drug product2015-02-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022360-00285011642029-06-14Drug product2013-09-05b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022360-00189407722029-04-30Drug product2015-02-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022360-00185011642029-06-14Drug product2013-09-0503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022360-00289407722029-04-30Drug product2015-02-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022360-00285011642029-06-14Drug product2013-09-0503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022360-00189407722029-04-30Drug product2015-02-252680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022360-00185011642029-06-14Drug product2013-09-052680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022360-00289407722029-04-30Drug product2015-02-252680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022360-00285011642029-06-14Drug product2013-09-052680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022360-00189407722029-04-30Drug product2015-02-255bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022360-00185011642029-06-14Drug product2013-09-055bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022360-00289407722029-04-30Drug product2015-02-255bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022360-00285011642029-06-14Drug product2013-09-055bbf6a4d5a75…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Nicorette Cherry PeppermintNICOTINE POLACRILEXHaleon US Holdings LLC35438b53-2760-bcfe-e063-6394a90a65c02025-06-09WarningsExact identifier
ndc (package): 0135-8071-20
ndc (package): 0135-8070-20
ndc (package): 0135-8070-81
ndc (package): 0135-8071-81
ndc (product): 0135-8070
ndc (product): 0135-8071
ndc11 (package): 00135807081
ndc11 (package): 00135807120
ndc11 (package): 00135807181
ndc11 (package): 00135807020
spl id: 3724f342-04db-e129-e063-6294a90a6c7d
spl set id: 35438b53-2760-bcfe-e063-6394a90a65c0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.